Skip to Content

Nutri Pharmaceuticals Research Inc NRPR

Morningstar Rating
$0.02 +0.01 (37.50%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NRPR is trading at a 38% discount.
Price
$0.02
Fair Value
$8.87
Uncertainty
Extreme
1-Star Price
$8.94
5-Star Price
$4.32
Economic Moat
Tzsqz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NRPR is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.02
Day Range
$0.020.02
52-Week Range
$0.010.03
Bid/Ask
$0.02 / $0.02
Market Cap
$2.32 Mil
Volume/Avg
100 / 7,772

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Nutri Pharmaceuticals Research Inc, through its subsidiary, is engaged in sales on amazon.com and in developing and marketing CBD products for consumers.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
Website

Valuation

Metric
NRPR
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NRPR
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
NRPR
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRGcqtmhmlvYqzgb$70.5 Bil
ZTS
Zoetis Inc Class AHnxnykclzqMkfxr$69.4 Bil
HLN
Haleon PLC ADRPlmjdbrmKzwg$36.6 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRMnfkyvwgMcml$14.9 Bil
VTRS
Viatris IncHjfzfkpqVrhb$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRMdmfsjbGslz$12.0 Bil
CTLT
Catalent IncWhxrmxpnCggdlqg$10.1 Bil
PRGO
Perrigo Co PLCXkgqrwkysXvlr$4.1 Bil
CURLF
Curaleaf Holdings IncTbfbvrmmrBkb$3.7 Bil
PBH
Prestige Consumer Healthcare IncBmstbcpdFqncxvl$3.4 Bil

Sponsor Center